| |
| |
|
| Insider
Information: |
Humer Franz B |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
257,922 |
|
|
Indirect Shares
|
21,304 |
|
|
| Direct
Value |
$165,264 |
|
|
|
Indirect Value
|
$1,319,144 |
|
|
| Total
Shares |
279,226 |
|
|
| Total
Value |
$1,484,408 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Citigroup Inc |
C |
Director |
2019-04-01 |
2,669 |
2019-04-01 |
21,304 |
Premium* |
|
|
Kite Pharma, Inc. |
KITE |
Director |
2017-10-03 |
0 |
2016-03-10 |
0 |
Premium* |
|
|
Allogene Therapeutics, Inc. |
ALLO |
|
2024-05-30 |
255,253 |
2018-10-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALLO |
Allogene Therapeutics, In... |
|
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
74,561 |
266,453 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
• • – |
2024-05-30 |
4 |
S |
$2.34 |
$26,181 |
D/D |
(11,200) |
255,253 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
44,178 |
191,892 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,498 |
147,714 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,969 |
131,216 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,377 |
121,247 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Director |
– • – |
2018-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
74,870 |
104,870 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Director |
– • – |
2018-10-15 |
4 |
B |
$18.00 |
$540,000 |
D/D |
30,000 |
30,000 |
2.39 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2019-04-01 |
4 |
A |
$63.05 |
$9,542 |
I/I |
151 |
21,304 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2019-01-02 |
4 |
A |
$58.01 |
$8,287 |
I/I |
143 |
18,513 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2018-10-01 |
4 |
A |
$70.35 |
$8,231 |
I/I |
117 |
18,370 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2018-07-01 |
4 |
A |
$67.57 |
$5,824 |
I/I |
86 |
18,253 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2018-04-01 |
4 |
A |
$74.44 |
$5,797 |
I/I |
78 |
18,167 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2018-01-02 |
4 |
A |
$75.63 |
$4,451 |
I/I |
59 |
13,954 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2017-10-01 |
4 |
A |
$67.95 |
$4,430 |
I/I |
65 |
13,895 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2017-07-01 |
4 |
A |
$62.77 |
$2,209 |
I/I |
35 |
13,829 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2017-04-01 |
4 |
A |
$61.11 |
$2,202 |
I/I |
36 |
13,794 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2017-01-03 |
4 |
A |
$58.65 |
$1,717 |
I/I |
29 |
10,759 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2016-10-01 |
4 |
A |
$47.31 |
$1,711 |
I/I |
36 |
10,729 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2016-07-01 |
4 |
A |
$45.02 |
$534 |
I/I |
12 |
10,693 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2016-04-01 |
4 |
A |
$42.10 |
$534 |
I/I |
13 |
10,681 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2014-04-01 |
4 |
A |
$48.54 |
$102 |
D/D |
2 |
10,630 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,020 |
10,628 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2016-01-01 |
4 |
A |
$53.31 |
$378 |
I/I |
7 |
7,637 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2015-10-01 |
4 |
A |
$51.28 |
$379 |
I/I |
7 |
7,630 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
